tiprankstipranks

Richard Lowenthal Insider Profile

4 Followers
Richard Lowenthal, VP at Cadence Pharma, holds 141.00K shares in Cadence Pharma (Ticker: CADX), holds 12.87M shares in ARS Pharmaceuticals (Ticker: SPRY). Most recently, Richard Lowenthal ― shares of Cadence Pharma on ― for an estimated value of ―.
tipranks
Richard Lowenthal

Richard Lowenthal
Cadence Pharma (CADX)
VP

Ranked #48,303 out of 98,624 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+1.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$120M
100.00%
A breakdown of Richard Lowenthal's holdings

Insider Roles

ARS Pharmaceuticals
(SPRY)
President & CEO, Director, Ten Percent Owner
Roles that Richard Lowenthal holds in companies

Most Profitable Insider Trade

Stock:
ARS Pharmaceuticals
(SPRY)
Rating:Informative Buy
Date:Apr 22, 2024 - Today
Return:+1.70%
The most profitable trade made by Richard Lowenthal

Richard Lowenthal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CADX
Cadence Pharma
ARS Pharmaceuticals
Apr 24, 2024
President & CEO, Director, Ten Percent Owner
Informative Buy
138.99K
$120.04M
List of latest transactions for each holding click on a transaction to see Richard Lowenthal's performance on stock

Richard Lowenthal insider profile FAQ

What is the percentage of profitable transactions made by Richard Lowenthal?
The percentage of profitable transactions made by Richard Lowenthal is 100%.
    What is the average return per transaction made by Richard Lowenthal?
    The average return per transaction made by Richard Lowenthal is 1.30%.
      What stocks does Richard Lowenthal hold?
      Richard Lowenthal holds: CADX, SPRY stocks.
        What was Richard Lowenthal’s latest transaction?
        Richard Lowenthal latest transaction was an Uninformative Buy of ―.
          What was Richard Lowenthal's most profitable transaction?
          Richard Lowenthal’s most profitable transaction was an Informative Buy of SPRY stock on April 22, 2024. The return on the trade was 1.70%.
            What is Richard Lowenthal's role in Cadence Pharma?
            Richard Lowenthal's role in Cadence Pharma is VP.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.